Back

Genotype-guided antiplatelet therapy after percutaneous coronary intervention: a systematic review and meta-analysis of randomised controlled trials.

30 August 2026 (15:15 - 16:00)
Organised by: Logo
Congress Presentation Part of: Updates on single and combined antithrombotic therapy Antiplatelet Drugs ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Armanda Buffon

IRCCS Foundation Agostino Gemelli University Hospital, Rome (Italy)

5 More presentations in this session

Presentation thumbnail
Effect of combined antiplatelet and anticoagulant therapy in comparison to anticoagulants in monotherapy on CABG outcomes in patients requiring anticoagulants. Analysis of real-world data.
Doctor A. Segiet-Swiecicka (Warsaw, PL)
Abstract Slides
Presentation thumbnail
BRIDGE: a barrier‑informed Bayesian risk prediction model for risk identification, trajectory grouping, and profiling of non‑adherence to cardioprotective medicines in primary care
Doctor H. Koh (Melbourne, AU) Assistant Professor S. Talic (Melbourne, AU)
Abstract Slides
Presentation thumbnail
Bleeding and mortality risks after intravenous alteplase in stroke patients with prior dual antiplatelet therapy: a nationwide cohort study
Doctor H. Huang (Hualien, TW)
Abstract Slides
Presentation thumbnail
Single vs. dual antithrombotic therapy in patients with stabilized coronary artery disease requiring long-term oral anticoagulation: A Bayesian meta-analysis
Doctor P. Sabouret (Paris, FR)
Abstract Slides
Presentation thumbnail
Antithrombotic therapy in patients with atrial fibrillation after percutaneous coronary intervention: a systematic review and individual patient data network meta-analysis.
Doctor C. Gibson (Boston, US) Assistant Professor M. Chiarito (Rozzano, IT)
Abstract Slides

Access the full session

Session thumbnail
Updates on single and combined antithrombotic therapy

The Event

Event poster

ESC Congress 2026

30 August 2026 15:15 CET
You may be interested in
thumbnail
Congress Presentation
Optimizing antiplatelet therapy in ACS: a network meta-analysis of simplified regimens
1 September 2025
thumbnail
Congress Presentation
Association between genetic polymorphisms in multiple thrombosis-related genes and long-term prognosis in coronary artery disease patients: a large-scale cohort study
1 September 2025
thumbnail
Congress Presentation
Platelet inhibitory profiles of prasugrel versus ticagrelor in patients with CYP2C19 loss-of-function genotypes undergoing percutaneous coronary intervention: results of a randomized feasibility study
1 September 2019
thumbnail
Congress Session
Pharmacogenetics: a tool to guide clinical decisions
27 August 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources